Published in Infect Immun on December 01, 2001
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood (2007) 3.09
CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production. Clin Immunol (2007) 1.64
Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge. Infect Immun (2002) 1.15
Inhibition of nitric oxide synthase by cobalamins and cobinamides. Free Radic Biol Med (2009) 0.91
High MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival time. PLoS One (2013) 0.86
Regional differences in prostaglandin E2 and nitric oxide production in the knee meniscus in response to dynamic compression. Biochem Biophys Res Commun (2007) 0.84
Contribution of nitric oxide to CpG-mediated protection against Listeria monocytogenes. Infect Immun (2005) 0.79
Expression of inducible nitric oxide synthase mRNA and nitric oxide production during the development of liver abscess in hamster inoculated with Entamoeba histolytica. Curr Microbiol (2005) 0.78
N-[3-(aminomethyl)benzyl]acetamidine (1400 W) as a potential immunomodulatory agent. Oxid Med Cell Longev (2014) 0.78
A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis. Hum Vaccin Immunother (2013) 0.77
Murine J774 macrophages recognize LPS/IFN-g, non-CpG DNA or two-CpG DNA-containing sequences as immunologically distinct. Nitric Oxide (2010) 0.75
Nitric Oxide (NO) and Cyclooxygenase-2 (COX-2) Cross-Talk in Co-Cultures of Tumor Spheroids with Normal Cells. Cancer Microenviron (2011) 0.75
Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol (1998) 7.22
Regulation of biosynthesis of nitric oxide. J Biol Chem (1994) 4.82
Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A (1993) 3.93
Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A (1994) 3.20
Macrophages ingest and are activated by bacterial DNA. J Immunol (1996) 2.64
Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J Exp Med (2000) 2.16
Bacterial CpG DNA activates immune cells to signal infectious danger. Adv Immunol (1999) 1.75
The role of CpG motifs in innate immunity. Curr Opin Immunol (2000) 1.74
Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest (1997) 1.70
Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol (1995) 1.63
Immune activation by bacterial DNA: a new genetic code. Immunity (1996) 1.63
Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med (1999) 1.61
Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur J Immunol (1997) 1.56
Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol (1992) 1.45
Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol (1993) 1.40
Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages. J Immunol (1999) 1.39
Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci U S A (1994) 1.33
Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest (1995) 1.33
Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J Immunol (1993) 1.30
The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc Natl Acad Sci U S A (1995) 1.22
Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis. FASEB J (1999) 1.13
The features of arthritis induced by CpG motifs in bacterial DNA. Arthritis Rheum (2000) 1.05
Bacterial DNA or oligonucleotides containing unmethylated CpG motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway. J Immunol (1999) 1.04
IFN-gamma primes macrophage responses to bacterial DNA. J Interferon Cytokine Res (1998) 1.02
Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol Chem Hoppe Seyler (1992) 1.01
Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides. Biochim Biophys Acta (1999) 1.01
Prostaglandin E2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774. Prostaglandins (1995) 0.99
Mechanisms and therapeutic applications of immune stimulatory cpG DNA. Pharmacol Ther (1999) 0.90
Nitric oxide production from macrophages is regulated by arachidonic acid metabolites. Biochem Biophys Res Commun (1993) 0.89
DNA and the immune system. Ann Intern Med (1997) 0.89
The influence of base sequence on the immunological properties of defined oligonucleotides. Immunopharmacology (1998) 0.80
Automated genome sequence analysis and annotation. Bioinformatics (1999) 13.92
Final act. Arthritis Care Res (1996) 10.22
A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet (2001) 4.17
Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc Natl Acad Sci U S A (1987) 3.90
Tumor necrosis factor alpha blockers and the induction of anti-DNA autoantibodies. Arthritis Rheum (2000) 3.10
Macrophage tumor killing: influence of the local environment. Science (1977) 2.94
Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med (1996) 2.75
Characterization of the effects of endotoxin on macrophage tumor cell killing. J Immunol (1978) 2.65
Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult Scler (2008) 2.44
The RNA component of the Bacillus subtilis RNase P. Sequence, activity, and partial secondary structure. J Biol Chem (1986) 2.28
Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med (1992) 2.27
Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha. Cell Immunol (1996) 2.02
Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol (1991) 2.02
Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun (2000) 1.94
The role of microparticles in inflammation and thrombosis. Scand J Immunol (2007) 1.93
Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity. J Infect Dis (2000) 1.90
CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J Immunol (1996) 1.90
Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Respir Dis (1990) 1.90
Recombinant human gamma-interferon induces human monocyte polykaryon formation. Proc Natl Acad Sci U S A (1984) 1.72
Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci. Arthritis Rheum (2001) 1.66
Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry (2006) 1.63
Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest (1996) 1.57
Fractal morphology, imaging and mass spectrometry of single aerosol particles in flight. Nature (2012) 1.56
Endocytosis of red blood cells or haemoglobin by activated macrophages inhibits their tumoricidal effect. Nature (1977) 1.55
The influence of the lpr gene on B cell activation: differential antibody expression in lpr congenic mouse strains. Clin Immunol Immunopathol (1984) 1.54
Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J Immunol (1989) 1.50
Interleukin-1, tumor necrosis factor-alpha, and transforming growth factor-beta 1 and integrative meniscal repair: influences on meniscal cell proliferation and migration. Arthritis Res Ther (2011) 1.47
Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood (1992) 1.47
Serial measurement of serum interleukin-2 receptor levels in patients with rheumatoid arthritis: limited evidence for a role of T cell activation in clinical exacerbations. Clin Immunol Immunopathol (1994) 1.41
Nitric oxide synthase 2(Lambaréné) (G-954C), increased nitric oxide production, and protection against malaria. J Infect Dis (2001) 1.40
The effects of static and intermittent compression on nitric oxide production in articular cartilage explants. J Orthop Res (2001) 1.38
Receptor-mediated modulation of human monocyte, neutrophil, lymphocyte, and platelet function by phorbol diesters. J Clin Invest (1982) 1.36
Interferon-beta1A-induced polyarthritis in a patient with the HLA-DRB1*0404 allele. Arthritis Rheum (1999) 1.35
The release of microparticles by apoptotic cells and their effects on macrophages. Apoptosis (2005) 1.32
V region gene analysis of anti-Sm hybridomas from MRL/Mp-lpr/lpr mice. J Immunol (1993) 1.32
Single-particle structure determination by correlations of snapshot X-ray diffraction patterns. Nat Commun (2012) 1.30
NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.27
Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression. Cancer Res (1993) 1.26
Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. Leukemia (2012) 1.26
Antibodies to DNA. A perspective. Arthritis Rheum (1986) 1.24
Specificity and idiotypic analysis of a monoclonal anti-Sm antibody with anti-DNA activity. J Immunol (1985) 1.20
Expression of high mobility group protein 1 in the sera of patients and mice with systemic lupus erythematosus. Ann Rheum Dis (2008) 1.20
Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest (1995) 1.20
Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J Exp Med (1996) 1.16
Monocyte chemotactic peptide receptor. Functional characteristics and ligand-induced regulation. J Clin Invest (1981) 1.16
The macrophage as an antineoplastic surveillance cell: biological perspectives. J Reticuloendothel Soc (1978) 1.15
Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis. Leukemia (2009) 1.15
Release of DNA from dead and dying lymphocyte and monocyte cell lines in vitro. Scand J Immunol (2004) 1.14
A simple enzyme-linked immunosorbent assay for antibodies to native DNA. J Immunol Methods (1981) 1.14
Genetic control of the immune response to nuclease. V. Genetic linkage and strain distribution of anti-nuclease idiotypes. J Exp Med (1977) 1.14
Nuclear expression of the 50- and 65-kD Rel-related subunits of nuclear factor-kappa B is differentially regulated in human monocytic cells. J Clin Invest (1992) 1.14
Induction of cyclooxygenase-2 by mechanical stress through a nitric oxide-regulated pathway. Osteoarthritis Cartilage (2002) 1.14
Ipr gene control of the anti-DNA antibody response. J Immunol (1982) 1.13
Mechanisms of autoantibody production in autoimmune MRL mice. J Exp Med (1980) 1.13
Measuring nitric oxide production in human clinical studies. Methods Enzymol (1999) 1.13
Reactive nitrogen and oxygen species in interleukin-1-mediated DNA damage associated with osteoarthritis. Osteoarthritis Cartilage (2007) 1.12
Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2. J Exp Med (1997) 1.11
Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis. Am J Med (1988) 1.10
The mechanism of autoantibody production in an autoimmune MRL/lpr mouse. J Immunol (1994) 1.08
Nanoplasma dynamics of single large xenon clusters irradiated with superintense x-ray pulses from the linac coherent light source free-electron laser. Phys Rev Lett (2012) 1.08
Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood (1988) 1.08
A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes Immun (2002) 1.07
Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL. Leukemia (2011) 1.07
Idiotypic analysis of a monoclonal anti-Sm antibody. J Immunol (1982) 1.07
The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers. Clin Pharmacol Ther (2012) 1.06
Erythrocyte anisocytosis. Visual inspection of blood films vs automated analysis of red blood cell distribution width. Arch Intern Med (1988) 1.06
Functional alterations of macrophages in autoimmune MRL-lpr/lpr mice. J Immunol (1987) 1.06
Tumor necrosis factor-alpha induces increased hydrogen peroxide production and Fc receptor expression, but not increased Ia antigen expression by peritoneal macrophages. J Leukoc Biol (1987) 1.06
Peritoneal fluid cell populations in infertility patients. Fertil Steril (1981) 1.05
Cellular CD44S as a determinant of human immunodeficiency virus type 1 infection and cellular tropism. J Virol (1995) 1.05
IgG antinuclear antibodies with cross-reactive rheumatoid factor activity. J Immunol (1986) 1.04
Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria. Infect Immun (1999) 1.02
Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells. Leuk Res (1995) 1.02
Thrombomodulin expression by human blood monocytes and by human synovial tissue lining macrophages. Blood (1991) 1.02
The effect of dynamic mechanical compression on nitric oxide production in the meniscus. Osteoarthritis Cartilage (2001) 1.01
Oxygen, nitric oxide and articular cartilage. Eur Cell Mater (2007) 1.01
Analysis of autoantibody binding to different regions of the human La antigen expressed in recombinant fusion proteins. J Immunol (1988) 1.00
Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages. J Virol (1991) 1.00